Bard Australia

Bard Australia is a leading medical technology company that operates as a subsidiary of BD (Becton Dickinson) following its acquisition in 2017. The company specializes in the development and distribution of medical devices across four primary areas: vascular, urology, oncology, and surgical specialties. Its extensive product portfolio includes vascular access devices, biopsy instruments, drainage systems, and advanced surgical meshes. Bard Australia provides essential clinical support and innovative solutions to healthcare professionals throughout Australia and New Zealand. The integration with BD has expanded its capabilities in delivering comprehensive care across the patient journey. Based in North Ryde, New South Wales, the company remains a vital provider of interventional medical technologies in the region.